| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4288740
Max Phase: Preclinical
Molecular Formula: C24H20FN7OS
Molecular Weight: 473.54
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=C(NCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3sccn23)n1)Nc1ccccc1
Standard InChI: InChI=1S/C24H20FN7OS/c25-17-8-6-16(7-9-17)20-21(32-14-15-34-24(32)31-20)19-10-11-26-22(30-19)27-12-13-28-23(33)29-18-4-2-1-3-5-18/h1-11,14-15H,12-13H2,(H,26,27,30)(H2,28,29,33)
Standard InChI Key: FRTWCYIAYBQRMN-UHFFFAOYSA-N
Associated Targets(Human)
UO-31 46270 Activities
MCF7 126967 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 473.54 | Molecular Weight (Monoisotopic): 473.1434 | AlogP: 4.89 | #Rotatable Bonds: 7 |
| Polar Surface Area: 96.24 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 13.57 | CX Basic pKa: 3.52 | CX LogP: 4.08 | CX LogD: 4.08 |
| Aromatic Rings: 5 | Heavy Atoms: 34 | QED Weighted: 0.29 | Np Likeness Score: -2.18 |
References
| 1. Ammar UM, Abdel-Maksoud MS, Oh CH.. (2018) Recent advances of RAF (rapidly accelerated fibrosarcoma) inhibitors as anti-cancer agents., 158 [PMID:30216849] [10.1016/j.ejmech.2018.09.005] |
Source
Source(1):